Norris Medicines Limited (BOM:524414)
12.87
-1.42 (-9.94%)
At close: Jan 21, 2026
Norris Medicines Market Cap
Norris Medicines has a market cap or net worth of 139.51 million as of January 23, 2026. Its market cap has decreased by -17.94% in one year.
Market Cap
139.51M
Enterprise Value
353.58M
Revenue
72.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.87
Market Cap Chart
Since December 3, 2001, Norris Medicines's market cap has increased from 34.30M to 139.51M, an increase of 306.73%. That is a compound annual growth rate of 5.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 139.51M | -12.54% |
| Dec 31, 2025 | 159.51M | -8.07% |
| Dec 31, 2024 | 173.51M | 27.48% |
| Dec 29, 2023 | 136.11M | -1.95% |
| Dec 30, 2022 | 138.81M | 29.72% |
| Dec 31, 2021 | 107.01M | 72.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zenith Healthcare | 184.86M |
| Desh Rakshak Aushdhalaya | 182.35M |
| Hamps Bio | 161.26M |
| Emmessar Biotech & Nutrition | 142.59M |
| Sunrest Lifescience | 137.75M |
| Colinz Laboratories | 127.72M |
| Cian Healthcare | 125.23M |
| Beryl Drugs | 116.14M |